Aclaris Therapeutics Stock Filter Stocks by Fundamentals

ACRS Stock  USD 1.26  0.08  6.78%   
Aclaris Therapeutics fundamentals help investors to digest information that contributes to Aclaris Therapeutics' financial success or failures. It also enables traders to predict the movement of Aclaris Stock. The fundamental analysis module provides a way to measure Aclaris Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aclaris Therapeutics stock.
Price To Book Ratio is likely to gain to 489.66 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aclaris Price to Book Analysis

Aclaris Price to Book Driver Correlations

Understanding the fundamental principles of building solid financial models for Aclaris Therapeutics is extremely important. It helps to project a fair market value of Aclaris Stock properly, considering its historical fundamentals such as Price to Book. Since Aclaris Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aclaris Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aclaris Therapeutics' interrelated accounts and indicators.
0.780.990.58-0.48-0.620.860.940.840.790.510.970.280.970.440.590.490.520.730.820.02-0.19-0.010.58-0.330.46
0.780.730.33-0.29-0.490.830.660.60.610.610.740.370.660.10.660.060.730.550.68-0.06-0.04-0.090.64-0.270.31
0.990.730.52-0.53-0.560.790.950.780.740.360.980.260.980.390.510.50.470.670.810.04-0.180.010.49-0.270.42
0.580.330.52-0.11-0.90.530.540.810.80.550.550.080.620.290.510.79-0.060.840.57-0.31-0.71-0.230.64-0.660.81
-0.48-0.29-0.53-0.110.13-0.34-0.58-0.28-0.260.07-0.52-0.26-0.480.07-0.05-0.14-0.03-0.21-0.460.040.030.020.010.02-0.03
-0.62-0.49-0.56-0.90.13-0.73-0.52-0.81-0.93-0.62-0.57-0.42-0.63-0.29-0.8-0.64-0.14-0.94-0.780.610.580.55-0.860.87-0.69
0.860.830.790.53-0.34-0.730.70.770.840.720.770.610.770.410.90.30.680.80.84-0.29-0.19-0.360.82-0.570.4
0.940.660.950.54-0.58-0.520.70.820.70.350.980.180.910.440.380.440.290.630.730.08-0.110.150.47-0.270.4
0.840.60.780.81-0.28-0.810.770.820.910.690.820.210.80.550.640.490.220.90.69-0.13-0.23-0.040.73-0.590.7
0.790.610.740.8-0.26-0.930.840.70.910.630.750.420.80.390.820.540.280.990.85-0.45-0.31-0.410.83-0.780.7
0.510.610.360.550.07-0.620.720.350.690.630.390.190.360.490.710.120.530.670.44-0.12-0.14-0.140.75-0.440.45
0.970.740.980.55-0.52-0.570.770.980.820.750.390.250.950.410.480.480.380.670.80.03-0.150.070.53-0.320.43
0.280.370.260.08-0.26-0.420.610.180.210.420.190.250.240.040.7-0.010.280.360.56-0.63-0.07-0.640.57-0.66-0.02
0.970.660.980.62-0.48-0.630.770.910.80.80.360.950.240.350.530.620.390.750.81-0.01-0.28-0.060.49-0.340.55
0.440.10.390.290.07-0.290.410.440.550.390.490.410.040.350.340.170.260.370.280.090.120.110.45-0.22-0.01
0.590.660.510.51-0.05-0.80.90.380.640.820.710.480.70.530.340.220.580.80.75-0.58-0.22-0.640.92-0.770.39
0.490.060.50.79-0.14-0.640.30.440.490.540.120.48-0.010.620.170.22-0.140.570.52-0.17-0.81-0.210.27-0.40.6
0.520.730.47-0.06-0.03-0.140.680.290.220.280.530.380.280.390.260.58-0.140.230.410.090.1-0.150.430.05-0.09
0.730.550.670.84-0.21-0.940.80.630.90.990.670.670.360.750.370.80.570.230.79-0.44-0.37-0.410.81-0.780.77
0.820.680.810.57-0.46-0.780.840.730.690.850.440.80.560.810.280.750.520.410.79-0.49-0.3-0.490.74-0.650.37
0.02-0.060.04-0.310.040.61-0.290.08-0.13-0.45-0.120.03-0.63-0.010.09-0.58-0.170.09-0.44-0.490.320.92-0.60.83-0.09
-0.19-0.04-0.18-0.710.030.58-0.19-0.11-0.23-0.31-0.14-0.15-0.07-0.280.12-0.22-0.810.1-0.37-0.30.320.38-0.280.38-0.45
-0.01-0.090.01-0.230.020.55-0.360.15-0.04-0.41-0.140.07-0.64-0.060.11-0.64-0.21-0.15-0.41-0.490.920.38-0.540.7-0.05
0.580.640.490.640.01-0.860.820.470.730.830.750.530.570.490.450.920.270.430.810.74-0.6-0.28-0.54-0.830.38
-0.33-0.27-0.27-0.660.020.87-0.57-0.27-0.59-0.78-0.44-0.32-0.66-0.34-0.22-0.77-0.40.05-0.78-0.650.830.380.7-0.83-0.48
0.460.310.420.81-0.03-0.690.40.40.70.70.450.43-0.020.55-0.010.390.6-0.090.770.37-0.09-0.45-0.050.38-0.48
Click cells to compare fundamentals
Competition

Aclaris Price Book Value Ratio

Price Book Value Ratio

489.66

At this time, Aclaris Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year.
Based on the latest financial disclosure, the price to book indicator of Aclaris Therapeutics is roughly 0.0null. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Price to Book (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Aclaris Fundamentals

About Aclaris Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aclaris Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aclaris Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aclaris Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Price To Book Ratio 466.34  489.66 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aclaris Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aclaris Therapeutics' short interest history, or implied volatility extrapolated from Aclaris Therapeutics options trading.

Pair Trading with Aclaris Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclaris Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Aclaris Stock

  0.67MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.64VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.53CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.51KA Kineta Inc Report 29th of March 2024 PairCorr
  0.44CVS CVS Health Corp Financial Report 1st of May 2024 PairCorr
The ability to find closely correlated positions to Aclaris Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclaris Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclaris Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclaris Therapeutics to buy it.
The correlation of Aclaris Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclaris Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclaris Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclaris Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aclaris Therapeutics is a strong investment it is important to analyze Aclaris Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclaris Therapeutics' future performance. For an informed investment choice regarding Aclaris Stock, refer to the following important reports:
Check out Aclaris Therapeutics Piotroski F Score and Aclaris Therapeutics Altman Z Score analysis.
For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Aclaris Stock analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Aclaris Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclaris Therapeutics. If investors know Aclaris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclaris Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Revenue Per Share
0.448
Quarterly Revenue Growth
1.266
Return On Assets
(0.33)
Return On Equity
(0.50)
The market value of Aclaris Therapeutics is measured differently than its book value, which is the value of Aclaris that is recorded on the company's balance sheet. Investors also form their own opinion of Aclaris Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aclaris Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclaris Therapeutics' market value can be influenced by many factors that don't directly affect Aclaris Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclaris Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclaris Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclaris Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.